Mirae Asset Sharekhan

DOWNLOAD SHAREKHAN APP

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Vivanza Biosciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Vivanza Biosciences Ltd

Fri 19/09/2025,16:1:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 2.13

Previous Close

₹ 2.08

Volume

108471

Mkt Cap ( Rs. Cr)

₹8.36

High

₹ 2.13

Low

₹ 2.05

52 Week High

₹ 4.36

52 Week Low

₹ 1.90

Book Value Per Share

₹ 1.23

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Vivanza Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vivanza Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Vivanza Biosciences - Reg. 34 (1) Annual Report.

4 Sep 2025, 3:41PM As per Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are submitting Annual Report for Financial year
Vivanza Biosciences - Annual Report

3 Sep 2025, 6:56PM As per Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are submitting Annual Report for Financial year
Vivanza Biosciences - Shareholding Meeting - 43Rd Annual General Meeting (AGM) On Thursday, September 25, 2025

3 Sep 2025, 6:48PM Notice of 43rd Annual General Meeting (AGM)
Vivanza Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday September 01, 2025 Related To 43Rd An

1 Sep 2025, 3:59PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Dir
Vivanza Biosciences - 43Rd AGM Related Agendas.

28 Aug 2025, 2:45PM Board Meeting to be held on Monday, 1st September 2025 to discuss, consider and approve the AGM related agendas.
Vivanza Biosciences - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of

28 Aug 2025, 2:29PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2025 ,inter alia, to consider
Vivanza Biosciences Q1 net profit down 91.30% at Rs 0.02 cr

13 Aug 2025, 6:10PM The company reported standalone net profit of Rs 0.02 crore for the quarter ended June 30, 2025 as compared to Rs 0.23 crore in the same period last y
Vivanza Biosciences - Financial Results For 30Th June, 2025

13 Aug 2025, 4:20PM The Board of Directors of the Company at its meeting held today i.e. Wednesday, August 13, 2025 at Registered Office of the Company has inter-alia has
Vivanza Biosciences - Board Meeting Outcome for Board Meeting Outcome

13 Aug 2025, 4:09PM The Board of Directors of the Company at its meeting held today i.e. Wednesday , August 13, 2025 at Registered Office of the Company has inter alia co
Vivanza Biosciences - Board Meeting Intimation for Consideration And Approved The Un-Audited Standalone And Consolidated Fina

8 Aug 2025, 2:29PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider
Vivanza Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

19 Jul 2025, 7:05AM As of June 2025, 20.02% is owned by Indian Promoters and 79.98% by Public. <p align=justify> Top two Promoters holding highest number of shares of Viv
Vivanza Biosciences - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligatio

14 Jul 2025, 3:02PM Non-Applicability of Statement of Deviation or Variation under Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201
Vivanza Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

14 Jul 2025, 2:29PM Certificate under Reg.74(5) of SEBI(DP), Regulations, 2018 for June Quarter ended

Key fundamentals

Evaluate the intrinsic value of Vivanza Biosciences Ltd stock

Name	March-25	March-24	March-23	March-22	March-21
Assets	10.113	7.9781	10.9623	5.5128	3.5404
Liabilities	10.113	7.9781	10.9623	5.5128	3.5404
Equity	4	4	4	4	4
Gross Profit	-0.3635	0.7998	0.7212	0.049	0.1259
Net Profit	-0.6951	0.3174	0.5691	0.4636	0.0998
Cash From Operating Activities	-2.4688	1.7835	0.1607	-0.6771	-3.0778
NPM(%)	-23.62	2.2	4	5.06	1.08
Revenue	2.9428	14.4132	14.2071	9.1475	9.2233
Expenses	3.3063	13.6134	13.4859	9.0984	9.0973
ROE(%)	-14.12	6.45	11.56	9.42	2.02

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2023	2024	Equity Share	4.00	4.00	40000000.00	1	4.00
2022	2023	Equity Share	4.00	4.00	40000000.00	1	4.00
2021	2022	Equity Share	4.00	4.00	4000000.00	10	4.00
2020	2021	Equity Share	4.00	4.00	4000000.00	10	4.00
2019	2020	Equity Share	4.00	4.00	4000000.00	10	4.00
2018	2019	Equity Share	4.00	4.00	4000000.00	10	4.00
2017	2018	Equity Share	4.00	4.00	4000000.00	10	4.00
2016	2017	Equity Share	4.00	4.00	4000000.00	10	4.00
2015	2016	Equity Share	4.00	0.19	188000.00	10	0.19
2014	2015	Equity Share	4.00	3.76	3760000.00	10	3.76
2013	2014	Equity Share	4.00	3.76	3760000.00	10	3.76
2012	2013	Equity Share	4.00	3.76	3760000.00	10	3.76
2011	2012	Equity Share	4.00	3.76	3760000.00	10	3.76
2010	2011	Equity Share	4.00	3.76	3760000.00	10	3.76
2009	2010	Equity Share	4.00	3.76	3760000.00	10	3.76
2001	2002	Equity Share	4.00	3.76	3760000.00	10	3.76
1999	2000	Equity Share	4.00	3.76	3760000.00	10	3.76
1996	1999	Equity Share	4.00	3.76	3760000.00	10	3.76
1995	1996	Equity Share	4.00	3.76	3760000.00	10	3.76

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Vivanza Biosciences Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	801.00	-1.01	72.72	1.17	301.39	0.62
Lotus Eye Hospital and Institute Ltd	119.50	-2.85	389.61	4.26	3.55	0.00
Bharat Immunological and Biologicals Corporation Ltd	22.01	0.23	0.00	8.85	-39.50	0.00
Astec Lifesciences Ltd	823.00	-1.44	0.00	4.02	-604.77	0.00

Company Info

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Read More

Parent Organisation

Vivanza Biosciences Ltd.

Founded

06/03/1982

Managing Director

Mr.J A Mehta

NSE Symbol

FAQ

The current price of Vivanza Biosciences Ltd is ₹ 2.09.

The 52-week high for Vivanza Biosciences Ltd is

The market capitalization of Vivanza Biosciences Ltd is currently ₹ 8.36. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vivanza Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vivanza Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vivanza Biosciences Ltd shares.

The CEO of Vivanza Biosciences Ltd is Mr.J A Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT